IRON Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.71%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $100,575,691.96

Disc Medicine Insider Trading History Chart

Disc Medicine Share Price & Price History

^$29.84

▲ +0.84 (2.90%)

As of 05/3/2024 04:49 PM ET

Days: 30 | 90 | 365

Biden replacement revealed?

From Paradigm Press | Ad

A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.

See his shocking evidence in this new report

Disc Medicine Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/11/2024	William Richard White	Director	Sell	2,560	$31.80	$81,408.00
1/23/2024	Kevin Bitterman	Director	Sell	102,500	$67.65	$6,934,125.00	198,326
1/23/2024	Venture Fund X L.P. Atlas	Major Shareholder	Sell	47,500	$67.65	$3,213,375.00	1,402,186
1/10/2024	Kevin Bitterman	Director	Sell	20,000	$64.00	$1,280,000.00	786,160
1/10/2024	Venture Fund X L.P. Atlas	Major Shareholder	Sell	30,000	$64.00	$1,920,000.00	1,449,686
12/18/2023	Mona Ashiya	Director	Sell	1,724	$59.24	$102,129.76
12/14/2023	Orbimed Advisors Llc	Director	Sell	200	$57.73	$11,546.00	727,807
12/14/2023	Venture Fund X L.P. Atlas	Major Shareholder	Sell	30,825	$58.28	$1,796,481.00	1,479,686
12/12/2023	Orbimed Advisors Llc	Director	Sell	27,300	$60.16	$1,642,368.00	295,605
12/12/2023	Venture Fund X L.P. Atlas	Major Shareholder	Sell	77,951	$62.80	$4,895,322.80	1,515,834
12/5/2023	Joanne Bryce	CFO	Sell	2,541	$56.00	$142,296.00	2,500
11/22/2023	Rahul Khara	General Counsel	Sell	10,000	$51.73	$517,300.00
11/14/2023	Rahul Khara	General Counsel	Sell	4,900	$50.61	$247,989.00
11/3/2023	Rahul Khara	General Counsel	Sell	100	$50.00	$5,000.00
9/16/2023	Venture Fund X L.P. Atlas	Major Shareholder	Sell	2,115	$53.22	$112,560.30	1,593,785
9/14/2023	Venture Fund X L.P. Atlas	Major Shareholder	Sell	94,440	$53.05	$5,010,042.00	1,856,794
9/1/2023	Joanne Bryce	CFO	Sell	1,000	$52.99	$52,990.00	1,260
8/15/2023	Kevin Bitterman	Director	Sell	72,931	$52.40	$3,821,584.40	882,224
8/15/2023	William Jacob Savage	insider	Sell	7,672	$52.95	$406,232.40
8/14/2023	Venture Fund X L.P. Atlas	Major Shareholder	Sell	175,000	$52.59	$9,203,250.00	2,062,303
8/9/2023	William Jacob Savage	Insider	Sell	8,269	$49.83	$412,044.27	7,672
8/1/2023	Joanne Bryce	CFO	Sell	4,521	$49.91	$225,643.11	1,260
6/30/2023	Brian Richard Macdonald	Insider	Sell	4,324	$45.05	$194,796.20	12,876
6/28/2023	Holdings A/S Novo	Major Shareholder	Sell	1,250,000	$46.10	$57,625,000.00	1,090,772
6/28/2023	Joanne Bryce	CFO	Sell	10,072	$49.95	$503,096.40	1,260
6/28/2023	William Jacob Savage	Insider	Sell	4,384	$49.98	$219,112.32	15,941

The AI Stock that’s Disrupting Every Industry

From StockEarnings | Ad

Move over Nvidia. There’s a new hot AI play that has soared 960% in the past year. One high-flying artificial intelligence stock has soared 960% over the past year and may soon become as familiar as Nvidia…

Here's the Ticker >>>

SEC Filings (Institutional Ownership Changes) for Disc Medicine (NASDAQ:IRON)

83.70% of Disc Medicine stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Disc Medicine Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/2/2024	Jennison Associates LLC	193,240	$12.03M	0.0%	+349.1%	0.800%
4/29/2024	China Universal Asset Management Co. Ltd.	4,641	$0.29M	0.0%	+66.2%	0.019%
4/24/2024	Simplicity Wealth LLC	4,566	$0.28M	0.0%	N/A	0.019%
3/22/2024	PNC Financial Services Group Inc.	10,000	$0.58M	0.0%	+149.4%	0.041%
3/5/2024	Wellington Management Group LLP	177,726	$10.27M	0.0%	+224.6%	0.736%
2/26/2024	Virtu Financial LLC	13,802	$0.80M	0.1%	N/A	0.057%
2/26/2024	Perceptive Advisors LLC	1,023,045	$59.09M	1.3%	+14.2%	4.238%
2/15/2024	Parkman Healthcare Partners LLC	92,871	$5.36M	0.8%	+78.4%	0.385%
2/15/2024	Frazier Life Sciences Management L.P.	785,000	$45.34M	2.4%	+19.8%	3.252%
2/14/2024	Pale Fire Capital SE	6,120	$0.35M	0.1%	N/A	0.025%
2/13/2024	Rafferty Asset Management LLC	39,863	$2.30M	0.0%	-36.9%	0.165%
2/12/2024	Fiduciary Trust Co	4,051	$0.23M	0.0%	N/A	0.017%
2/9/2024	Atlas Venture Life Science Advisors LLC	2,555,172	$147.59M	17.6%	-6.9%	10.585%
2/9/2024	Franklin Resources Inc.	221,424	$12.79M	0.0%	+37.5%	0.917%
2/9/2024	PNC Financial Services Group Inc.	10,000	$0.58M	0.0%	+149.4%	0.041%
2/8/2024	Nicholas Investment Partners LP	40,494	$2.34M	0.3%	N/A	0.168%
2/8/2024	First Turn Management LLC	157,274	$9.08M	1.3%	N/A	0.652%
2/7/2024	Jump Financial LLC	4,306	$0.25M	0.0%	N/A	0.018%
2/6/2024	Charles Schwab Investment Management Inc.	89,725	$5.18M	0.0%	+6.6%	0.372%
2/6/2024	AJOVista LLC	1,091	$63K	0.1%	N/A	0.005%
2/6/2024	Swiss National Bank	15,800	$0.91M	0.0%	-9.2%	0.065%
2/5/2024	Victory Capital Management Inc.	187,580	$10.84M	0.0%	+36.4%	0.777%
2/1/2024	New York State Common Retirement Fund	9,686	$0.56M	0.0%	+194.1%	0.040%
2/1/2024	Jennison Associates LLC	43,031	$2.49M	0.0%	N/A	0.178%
1/30/2024	Strs Ohio	1,000	$57K	0.0%	+66.7%	0.004%
1/29/2024	Simplicity Solutions LLC	3,716	$0.22M	0.0%	N/A	0.015%
1/25/2024	Bleakley Financial Group LLC	3,716	$0.22M	0.0%	N/A	0.015%
1/24/2024	China Universal Asset Management Co. Ltd.	2,793	$0.16M	0.0%	N/A	0.012%
1/16/2024	Legato Capital Management LLC	5,273	$0.31M	0.0%	N/A	0.022%
1/12/2024	SG Americas Securities LLC	9,135	$0.53M	0.0%	N/A	0.038%
12/18/2023	Vanguard Group Inc.	665,452	$31.26M	0.0%	+18.9%	2.757%
12/7/2023	Hudson Bay Capital Management LP	42,000	$1.97M	0.0%	N/A	0.174%
12/1/2023	Wellington Management Group LLP	54,745	$2.57M	0.0%	+26.5%	0.227%
11/22/2023	Polar Capital Holdings Plc	546,915	$25.69M	0.2%	-98.7%	2.266%
11/15/2023	Acuta Capital Partners LLC	138,198	$6.49M	4.4%	-0.9%	0.604%
11/15/2023	Adage Capital Partners GP L.L.C.	1,308,405	$61.47M	0.1%	+12.5%	5.719%
11/15/2023	Alps Advisors Inc.	16,900	$0.79M	0.0%	+16.1%	0.074%
11/14/2023	Schonfeld Strategic Advisors LLC	12,700	$0.60M	0.0%	+76.4%	0.056%
11/14/2023	Trexquant Investment LP	12,534	$0.59M	0.0%	N/A	0.055%
11/14/2023	Profund Advisors LLC	10,552	$0.50M	0.0%	N/A	0.046%
11/13/2023	Atlas Venture Life Science Advisors LLC	2,745,335	$128.98M	20.0%	-20.7%	11.999%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	16,642	$0.78M	0.0%	N/A	0.073%
11/13/2023	CHI Advisors LLC	25,000	$1.17M	0.4%	-80.0%	0.109%
11/13/2023	EAM Investors LLC	51,111	$2.40M	0.5%	+8.3%	0.223%
11/13/2023	Invesco Ltd.	161,213	$7.57M	0.0%	+45.7%	0.705%
11/13/2023	FMR LLC	305,433	$14.35M	0.0%	-5.5%	1.335%
11/13/2023	Rafferty Asset Management LLC	63,132	$2.97M	0.0%	N/A	0.276%
11/9/2023	Citigroup Inc.	26,547	$1.25M	0.0%	+1,053.2%	0.116%
11/8/2023	Charles Schwab Investment Management Inc.	84,200	$3.96M	0.0%	+309.6%	0.368%
11/8/2023	Swiss National Bank	17,400	$0.82M	0.0%	N/A	0.076%
11/7/2023	Virtus ETF Advisers LLC	2,014	$95K	0.1%	-9.2%	0.009%
11/7/2023	Barclays PLC	31,561	$1.48M	0.0%	+1,932.3%	0.138%
11/6/2023	Assenagon Asset Management S.A.	74,164	$3.48M	0.0%	-70.0%	0.324%
11/6/2023	Victory Capital Management Inc.	137,523	$6.46M	0.0%	N/A	0.601%
10/27/2023	TD Asset Management Inc	20,214	$0.95M	0.0%	+260.5%	0.088%
10/26/2023	Strs Ohio	600	$28K	0.0%	N/A	0.003%
10/24/2023	Bank of New York Mellon Corp	30,550	$1.44M	0.0%	+22.3%	0.134%
9/21/2023	Barclays PLC	1,553	$69K	0.0%	-72.4%	0.007%
8/24/2023	Perceptive Advisors LLC	742,838	$32.98M	1.0%	N/A	3.752%
8/22/2023	CHI Advisors LLC	125,139	$5.56M	1.7%	N/A	0.632%
8/15/2023	Sphera Funds Management LTD.	170,578	$7.57M	1.2%	-22.5%	0.862%
8/15/2023	Bain Capital Life Sciences Investors LLC	1,332,548	$59.17M	6.1%	-33.1%	6.730%
8/14/2023	Cormorant Asset Management LP	225,000	$9.99M	0.6%	N/A	1.136%
8/14/2023	Rock Springs Capital Management LP	363,468	$16.14M	0.4%	+16.0%	1.836%
8/14/2023	Polar Capital Holdings Plc	426,612	$18.94M	0.1%	N/A	2.155%
8/14/2023	Ghisallo Capital Management LLC	20,000	$0.89M	0.1%	N/A	0.101%
8/11/2023	Harvard Management Co. Inc.	8,452	$0.38M	0.0%	-66.2%	0.043%
8/11/2023	Franklin Resources Inc.	157,255	$6.98M	0.0%	N/A	0.794%
8/11/2023	ExodusPoint Capital Management LP	52,800	$2.34M	0.0%	-25.6%	0.267%
8/10/2023	Monashee Investment Management LLC	45,000	$2M	0.5%	N/A	0.227%
8/9/2023	TD Asset Management Inc	5,607	$0.25M	0.0%	N/A	0.028%
8/4/2023	American International Group Inc.	3,723	$0.17M	0.0%	N/A	0.019%
7/25/2023	Assenagon Asset Management S.A.	247,400	$10.99M	0.0%	+300.3%	1.249%
7/13/2023	Thompson Davis & CO. Inc.	6,800	$0.30M	0.3%	N/A	0.034%
5/16/2023	Bain Capital Life Sciences Investors LLC	1,990,914	$42.19M	5.3%	N/A	10.480%
5/15/2023	Logos Global Management LP	525,000	$11.13M	1.6%	N/A	2.763%
5/15/2023	Ghost Tree Capital LLC	100,000	$2.12M	0.6%	N/A	0.526%
5/11/2023	ExodusPoint Capital Management LP	70,966	$1.50M	0.0%	+134.7%	0.374%
4/18/2023	Assenagon Asset Management S.A.	61,805	$1.31M	0.0%	-9.7%	0.325%
4/14/2023	BML Capital Management LLC	208,161	$4.41M	3.8%	-58.4%	1.096%
2/15/2023	Atlas Venture Life Science Advisors LLC	3,461,784	$68.86M	8.3%	N/A	79.949%
2/15/2023	Nantahala Capital Management LLC	162,762	$3.06M	0.2%	N/A	3.759%
2/14/2023	Boxer Capital LLC	130,000	$0.18M	0.0%	N/A	3.002%
2/13/2023	BML Capital Management LLC	500,000	$9.95M	9.5%	N/A	11.539%
2/13/2023	Foresite Capital Management V LLC	243,513	$4.84M	3.8%	N/A	5.620%
2/10/2023	Harvard Management Co. Inc.	25,000	$0.50M	0.1%	N/A	0.577%
2/8/2023	UBS Group AG	7,115	$0.14M	0.0%	N/A	0.164%

Data available starting January 2016

Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, primarily heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for the treatment of erythropoietic porphyrias, including erythropoietic protoporphyria, X-linked protoporphyria, and diamond-blackfan anemia; DISC-0974 for the treatment of anemia of myelofibrosis, and anemia of chronic kidney disease; and DISC-3405 for the treatment of polycythemia vera, and other hematologic disorders. The company's preclinical programs include DISC-0998, for the treatment of anemia associated with inflammatory diseases. Disc Medicine, Inc. was founded in 2017 and is headquartered in Watertown, Massachusetts.

Today's Range

Now: $29.84

$29.39

$30.38

50 Day Range

MA: $48.02

$26.52

$75.32

52 Week Range

Now: $29.84

$25.60

$77.60

Volume

183,967 shs

Average Volume

415,416 shs

Market Capitalization

$720.34 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.44

Who are the company insiders with the largest holdings of Disc Medicine?: Disc Medicine's top insider shareholders include:
Venture Fund X LP Atlas (Major Shareholder)
Holdings A/S Novo (Major Shareholder)
Kevin Bitterman (Director)
Orbimed Advisors Llc (Director)
William Jacob Savage (Insider)
Brian Richard Macdonald (Insider)
Joanne Bryce (CFO)
Mona Ashiya (Director)
Rahul Khara (General Counsel)
William Richard White (Director)
Learn More about top insider investors at Disc Medicine.
Who are the major institutional investors of Disc Medicine?: Disc Medicine's top institutional investors include:
Jennison Associates LLC — 0.80%
China Universal Asset Management Co. Ltd. — 0.02%
Simplicity Wealth LLC — 0.02%
Learn More about top institutional investors of Disc Medicine stock.
Which institutional investors are buying Disc Medicine stock?: During the last quarter, IRON stock was acquired by institutional investors including:
Jennison Associates LLC
Simplicity Wealth LLC
China Universal Asset Management Co. Ltd.